DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Kaufmann M, Bajetta E, Dirix LY. et al.
Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study Group.
J Clin Oncol 2000;
18: 1399-1411
doi:10.1200/JCO.2000.18.7.1399
We do not assume any responsibility for the contents of the web pages of other providers.